PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-02

Date Title Company
02-Feb-2023 Formycon and Fresenius Kabi conclude global commercialization partnership for FYB202, a biosimilar candidate to Stelara®1 (ustekinumab) Formycon AG
02-Feb-2023 Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19 Biophytis
02-Feb-2023 Wound Debridement Products Market totaling around US$ 857.55 Billion by 2032 MARKITWIRED
02-Feb-2023 Cancer Supportive Care Products Market is likely to record a value of US$ 20.63 Billion in 2022 MARKITWIRED
02-Feb-2023 Dermatology Devices Market Europe is expected to register a growth of 7.3% from 2022 to 2032 MARKITWIRED
02-Feb-2023 Prosthetic Heart Valve Market is likely to touch a valuation of US$ 12.3 Billion by 2022 MARKITWIRED
02-Feb-2023 Formycon AG announces result of private placement and sets placement price for the new shares from the capital increase Formycon AG
02-Feb-2023 GCC Medical Gloves Market Expanding at a 7.9% CAGR from 2022 to 2032 MARKITWIRED
02-Feb-2023 Excimer and Femtosecond Ophthalmic Lasers Market are projected to rise at 8.0% CAGR from (2022-2032) MARKITWIRED
02-Feb-2023 Protein A Resins Market Japan is expected to exhibit healthy growth of 7.8% CAGR during the forecast period MARKITWIRED
02-Feb-2023 Thyroid Function Test Market size is estimated to cross US$ 38.85 Million by 2032 MARKITWIRED
02-Feb-2023 Breast Pumps Market valuation of US$ 2.45 Billion by the end of 2030, up from US$ 1.72 Billion in 2022 MARKITWIRED
02-Feb-2023 Negative Pressure Wound Therapy Market is projected to grow at a steady CAGR of 5.2% from 2022 to 2032 MARKITWIRED
02-Feb-2023 Laboratory Information Systems (LIS) Market Sales are forecast to grow at a 10.2% CAGR from 2022 to 2032 MARKITWIRED
02-Feb-2023 Respiratory Inhaler Devices Market to grow at 4.4% CAGR through 2030 MARKITWIRED
02-Feb-2023 U.S. Compounding Pharmacies Market is expected to grow at over 5.1% CAGR between 2022 and 2028 MARKITWIRED
02-Feb-2023 Shionogi’s Innovative Antibiotic, FETCROJA® (cefiderocol), Is Now Available in Denmark Businesswire